Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Avinger Inc (AVGR)

Avinger Inc (AVGR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 62,604
  • Shares Outstanding, K 95,564
  • Annual Sales, $ 8,760 K
  • Annual Income, $ -19,010 K
  • 60-Month Beta 1.65
  • Price/Sales 6.96
  • Price/Cash Flow N/A
  • Price/Book 5.41
Trade AVGR with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.24
  • Most Recent Earnings N/A on 11/12/21
  • Next Earnings Date 11/11/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/21
See More
  • Average Estimate -0.06
  • Number of Estimates 1
  • High Estimate -0.06
  • Low Estimate -0.06
  • Prior Year -0.07
  • Growth Rate Est. (year over year) +14.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6011 +4.79%
on 11/26/21
0.9630 -34.59%
on 11/17/21
-0.0887 (-12.34%)
since 10/26/21
3-Month
0.6011 +4.79%
on 11/26/21
0.9630 -34.59%
on 11/17/21
-0.2122 (-25.20%)
since 08/26/21
52-Week
0.2700 +133.30%
on 11/30/20
2.6700 -76.41%
on 02/18/21
+0.3423 (+119.02%)
since 11/25/20

Most Recent Stories

More News
Avinger Announces FDA Clearance of Pantheris for the Treatment of In-Stent Restenosis

New indication expands addressable market for Pantheris REDWOOD CITY, CA / ACCESSWIRE / November 17, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and...

AVGR : 0.6299 (-3.85%)
Avinger: Q3 Earnings Snapshot

REDWOOD CITY, Calif. (AP) _ Avinger Inc. (AVGR) on Thursday reported a loss of $4.9 million in its third quarter.

AVGR : 0.6299 (-3.85%)
Avinger Reports Third Quarter 2021 Financial Results

REDWOOD CITY, CA / ACCESSWIRE / November 11, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system...

AVGR : 0.6299 (-3.85%)
Avinger (AVGR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Avinger (AVGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AVGR : 0.6299 (-3.85%)
Avinger to Announce Third Quarter Results on November 11, 2021

REDWOOD CITY, CA / ACCESSWIRE / October 29, 2021 / Avinger, Inc. (NASDAQ:AVGR), commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...

AVGR : 0.6299 (-3.85%)
Ground-Breaking Clinical Data from INSIGHT Trial Presented at VIVA

Study Outcomes Demonstrate Safety and Efficacy of Pantheris for Treatment of In-Stent Restenosis REDWOOD CITY, CA / ACCESSWIRE / October 7, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical...

AVGR : 0.6299 (-3.85%)
Avinger To Present at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15

REDWOOD CITY, CA / ACCESSWIRE / September 8, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system...

AVGR : 0.6299 (-3.85%)
Avinger OCT-Guided Technologies Featured at AMP 2021

REDWOOD CITY, CA / ACCESSWIRE / August 16, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...

AVGR : 0.6299 (-3.85%)
Avinger Reports Second Quarter 2021 Financial Results

Pantheris Sales and Tigereye™ Expansion Drive 91% Year-Over-Year Revenue Growth REDWOOD CITY, CA / ACCESSWIRE / August 10, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company...

AVGR : 0.6299 (-3.85%)
Avinger Announces 510(k) Filing for New Lightbox 3 Imaging Console

Smaller Footprint, Improved User Experience and Lower Cost to Drive Adoption REDWOOD CITY, CA / ACCESSWIRE / August 9, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing...

AVGR : 0.6299 (-3.85%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Avinger, Inc. is engaged in designing, manufacturing and selling image-guided, catheter-based systems to treat peripheral arterial disease. The company's product consists of Lightbox imaging console, Wildcat, Kittycat, Ocelot, Ocelot PIXL, Ocelot MVRX and Juicebox. Avinger, Inc. is based in Redwood City,...

See More

Key Turning Points

3rd Resistance Point 0.7300
2nd Resistance Point 0.6984
1st Resistance Point 0.6642
Last Price 0.6299
1st Support Level 0.5984
2nd Support Level 0.5668
3rd Support Level 0.5326

See More

52-Week High 2.6700
Fibonacci 61.8% 1.7532
Fibonacci 50% 1.4700
Fibonacci 38.2% 1.1868
Last Price 0.6299
52-Week Low 0.2700

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar